At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 58 enrolled
Drug / intervention
Nix Creme Rinse Lice Treatment +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treatment of Infestation With Pediculus Humanus Capitis in the Community Using a leave-in Spray: A Prospective, Randomised Controlled Study
In Brief
A Phase 4 clinical trial evaluating Vamousse Spray 'n' Go and Nix Creme Rinse Lice Treatment for Pediculosis Capitis and 2 related conditions. Completed, enrolled 58 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the safety and efficacy of Vamousse Spray 'n' Go, compared to a 1% Permethrin control shampoo, in the treatment of head lice.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPediculosis Capitis, Lice Infestations, Head Lice
CountriesUnited States
CollaboratorsSouth Florida Family Health and Research Centers
Timeline
Phase 4CompletedFinished
2023202420252026
First PostedOct 2022
Enrollment StartDec 2022
Primary CompletionMar 2023
TodayJul 2026
First PostedOct 4, 2022
Enrollment StartDec 15, 2022
Primary CompletionMar 12, 2023
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 3.7 years ago
Interventions
Vamousse Spray 'n' Goother
Pediculicide for topical application, active ingredient Natrum Muriaticum 2X (HPUS).
Nix Creme Rinse Lice Treatmentdrug
1% permethrin lotion for topical application.